Last Close
Feb 20  •  04:00PM ET
0.6120
Dollar change
-0.0192
Percentage change
-3.04
%
Index- P/E- EPS (ttm)-1.03 Insider Own53.39% Shs Outstand5.02M Perf Week-2.86%
Market Cap3.07M Forward P/E- EPS next Y- Insider Trans0.00% Shs Float2.34M Perf Month-50.24%
Enterprise Value6.35M PEG- EPS next Q- Inst Own0.58% Short Float1.00% Perf Quarter-59.74%
Income-3.19M P/S0.76 EPS this Y- Inst Trans-35.95% Short Ratio0.41 Perf Half Y-57.20%
Sales4.05M P/B0.36 EPS next Y- ROA-21.66% Short Interest0.02M Perf YTD-49.42%
Book/sh1.69 P/C10.59 EPS next 5Y- ROE-42.47% 52W High3.18 -80.75% Perf Year-71.93%
Cash/sh0.06 P/FCF19.19 EPS past 3/5Y58.09% 59.12% ROIC-37.00% 52W Low0.60 2.00% Perf 3Y-98.73%
Dividend Est.- EV/EBITDA- Sales past 3/5Y-22.27% -16.15% Gross Margin-27.06% Volatility12.13% 14.85% Perf 5Y-99.89%
Dividend TTM- EV/Sales1.57 EPS Y/Y TTM69.90% Oper. Margin-79.83% ATR (14)0.11 Perf 10Y-99.08%
Dividend Ex-Date- Quick Ratio0.10 Sales Y/Y TTM-26.92% Profit Margin-78.72% RSI (14)22.47 Recom-
Dividend Gr. 3/5Y- - Current Ratio0.35 EPS Q/Q73.96% SMA20-28.25% Beta1.20 Target Price-
Payout- Debt/Eq0.42 Sales Q/Q-31.26% SMA50-46.94% Rel Volume0.29 Prev Close0.63
Employees231 LT Debt/Eq0.02 Earnings- SMA200-61.76% Avg Volume57.41K Price0.61
IPOApr 17, 2002 Option/ShortNo / Yes EPS/Sales Surpr.- - Trades Volume16,462 Change-3.04%
Date Action Analyst Rating Change Price Target Change
Jan-08-10Initiated Rodman & Renshaw Mkt Outperform $6
Apr-04-25 04:05PM
Dec-18-24 08:30AM
Dec-13-24 08:00AM
Aug-19-24 08:00AM
Feb-23-24 04:05PM
08:00AM Loading…
Nov-29-23 08:00AM
Aug-23-23 07:34PM
Aug-09-23 08:30AM
Feb-24-23 04:05PM
Dec-28-22 08:00AM
Dec-15-22 08:00AM
Dec-05-22 08:00AM
Dec-02-22 04:10PM
Oct-01-22 10:05PM
Jul-18-22 08:00AM
05:00PM Loading…
Jun-22-22 05:00PM
Mar-31-22 08:00AM
Nov-12-21 04:30PM
Aug-13-21 04:30PM
Aug-05-21 09:00AM
Jun-09-21 08:00AM
May-14-21 04:30PM
Apr-19-21 08:30AM
Mar-26-21 05:00PM
Nov-13-20 04:10PM
Oct-11-20 09:23AM
Sep-21-20 08:30AM
Aug-14-20 06:30AM
Aug-11-20 10:10AM
Jun-04-20 07:59PM
06:30AM Loading…
May-15-20 06:30AM
Apr-15-20 08:00AM
Apr-14-20 04:30PM
07:10AM
Apr-05-20 01:17AM
Mar-31-20 06:30AM
Mar-13-20 08:30AM
Mar-02-20 07:00AM
Dec-31-19 08:01AM
Nov-15-19 08:00AM
Oct-28-19 07:39AM
Sep-13-19 07:17AM
Sep-11-19 08:00AM
Sep-06-19 08:31AM
Aug-15-19 06:30AM
May-21-19 07:56PM
May-15-19 06:00AM
May-07-19 08:00AM
Mar-29-19 06:00AM
Jan-08-19 12:58PM
Nov-23-18 08:55AM
Nov-15-18 06:00AM
Nov-13-18 08:00AM
Nov-12-18 08:00AM
Oct-10-18 06:44PM
Aug-15-18 06:00AM
Aug-06-18 08:45AM
May-15-18 08:00AM
06:00AM
May-08-18 08:00AM
Apr-06-18 07:40AM
Apr-05-18 07:10AM
Apr-03-18 06:00AM
Mar-22-18 08:00AM
Dec-01-17 07:58AM
Nov-15-17 06:00AM
Nov-08-17 12:20PM
Nov-07-17 08:00AM
Oct-24-17 03:48PM
Sep-26-17 12:03PM
Sep-14-17 07:40AM
Sep-12-17 04:05PM
Aug-16-17 10:08AM
Aug-15-17 06:00AM
Aug-08-17 06:00AM
May-24-17 09:18AM
May-17-17 08:30AM
May-12-17 06:00AM
May-08-17 06:00AM
Apr-04-17 08:41AM
Mar-31-17 06:11AM
06:00AM
Mar-27-17 06:00AM
Dec-28-16 04:06PM
Dec-13-16 04:08PM
Dec-02-16 04:11PM
Nov-22-16 01:04PM
Nov-18-16 11:50AM
Nov-15-16 06:00AM
Nov-14-16 04:12PM
Nov-07-16 08:00AM
Aug-12-16 06:00AM
Aug-11-16 04:27PM
Aug-01-16 06:00AM
Jun-06-16 12:12PM
May-17-16 06:00AM
May-16-16 05:17PM
May-05-16 06:00AM
Apr-05-16 11:33AM
10:27AM
China Pharma Holdings, Inc. engages in the development, manufacture, and marketing of pharmaceutical products. The firm's product portfolio includes Central Nervous System (CNS) and Cerebral-Cardiovascular Diseases, Anti-infection and Respiratory Diseases, Digestive Diseases, Comprehensive Healthcare, and Protective Products. The company was founded by Zhi Lin Li on January 28, 1999 and is headquartered in Haikou, China.